Profound Medical/$PROF
1D1W1MYTD1Y5YMAX
About Profound Medical
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.
- Ticker
- $PROF
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 162
- Headquarters
- Mississauga, Canada
- Website
- www.profoundmedical.com
Profound Medical Metrics
BasicAdvanced
$254M
-
-$0.98
0.53
-
Price and volume
Market cap
$254M
Beta
0.53
52-week high
$8.95
52-week low
$3.76
Average daily volume
125K
Financial strength
Current ratio
6.459
Quick ratio
5.255
Long term debt to equity
5.529
Total debt to equity
14.817
Profitability
EBITDA (TTM)
-34.878
Gross margin (TTM)
71.79%
Net profit margin (TTM)
-171.56%
Operating margin (TTM)
-185.31%
Effective tax rate (TTM)
-0.70%
Revenue per employee (TTM)
$120,000
Management effectiveness
Return on assets (TTM)
-39.46%
Return on equity (TTM)
-73.53%
Valuation
Price to revenue (TTM)
12.168
Price to book
7.07
Price to tangible book (TTM)
7.09
Price to free cash flow (TTM)
-6.39
Free cash flow yield (TTM)
-15.65%
Free cash flow per share (TTM)
-1.089
Growth
Revenue change (TTM)
61.20%
Earnings per share change (TTM)
-33.49%
3-year revenue growth (CAGR)
41.38%
3-year earnings per share growth (CAGR)
-10.55%
10-year earnings per share growth (CAGR)
-8.34%
What the Analysts think about Profound Medical
Analyst ratings (Buy, Hold, Sell) for Profound Medical stock.
Profound Medical Financial Performance
Revenues and expenses
Profound Medical Earnings Performance
Company profitability
Profound Medical News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.